Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in southern China


  • The first two authors contributed equally to this study.

Corresponding author: Y.-M. Fan, Department of Dermatology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China.



The clinicopathological and microbiological features of chromoblastomycosis caused by Fonsecaea pedrosoi or Fonsecaea monophora are summarized. Four F. monophora and three F. pedrosoi strains were isolated from seven consecutive chromoblastomycosis patients and identified by genetic analysis between 2004 and 2012 in a teaching hospital in southern China. Six strains were sensitive to voriconazole, itraconazole and terbinafine using E-test and Neo-Sensitabs. Six patients healed after oral itraconazole or terbinafine, and one was lost to follow up. Internal transcribed spacer sequence is sufficient for species delimitation of Fonsecaea, and the Neo-Sensitabs test and E-test are comparable in their susceptibility testing. Itraconazole and/or terbinafine may be the preferred treatment for this chromoblastomycosis.